Adoption of the income statements and the balance sheets
The Annual General Meeting approved the income statements and the balance sheets for the fiscal year 2022.
The Annual General Meeting resolved, in accordance with the proposal of the Board of Directors that no dividend should be paid for the fiscal year 2022.
The Annual General Meeting discharged the Board members and the Chief Executive Officer from liability for the fiscal year 2022.
Board of Directors
In accordance with the proposal of the Nomination Committee, the Annual General Meeting resolved that the Board of Directors shall consist of four persons and no deputies.
The Annual General Meeting resolved, in accordance with the proposal of the Nomination Committee, on re-election of Nikolaj Sörensen, Kerstin Valinder Strinnholm and
The Annual General Meeting resolved, in accordance with the proposal of the Nomination Committee, that an unchanged aggregate annual fee of
Fees to the Auditors, for a period until the end of the next Annual General Meeting, are to be paid as per approved invoice.
Nomination Committee
The Annual General Meeting resolved, in accordance with the proposal of the Nomination Committee, that the Company shall have a Nomination Committee consisting of three members. The Nomination Committee shall comprise one representative of each of the two largest shareholders or owner groups in the Company in terms of votes as per
Principles for remuneration
The Annual General Meeting resolved to approve the
Remuneration report
The Annual General Meeting resolved to approve the
Reverse share split and amendments to the articles of association
The Annual General Meeting resolved, in accordance with the Board of Directors' proposal on a reverse share split and amendments of the limits for the share capital and the number of shares in the articles of association. The reverse share split will be carried out by ten (10) existing shares consolidating into one (1) share (Sw: Sammanläggning 1:10). If a shareholder's holding of shares does not correspond to a full number of shares, the excessive shares will pass to the Company at the record date of the reverse share split. Excessive share will thereafter be sold by the Company at the Company's expense, whereby concerned shareholders will receive their part of the sales proceeds. The Annual General Meeting also resolved to authorize the Board of Directors to determine the record date for the reverse share split. Following the reverse share split, the number of shares in the Company will decrease from 100,859,335 to 10,085,933. The proposed reverse share split will result in a change of the share's quotient value from
The resolution to amend the limits of the share capital in the articles of association means that the share capital shall be not less than
Implementation of LTI 2023
The Annual General Meeting also resolved to approve the
Authorization to issue shares
The Annual General Meeting resolved, in accordance with the proposal of the Board of Directors, to authorize the Board of Directors to, within the scope of the articles of association, with or without deviation from the shareholders' pre-emptive rights, on one or several occasions during the period until the next Annual General Meeting, resolve to increase the Company's share capital by issuing new shares in the Company. The total number of shares issued in accordance with this authorisation may be equivalent to a maximum of twenty (20) per cent of the shares in the Company at the first time the Board of Directors makes a resolution by virtue of the authorization.
Minutes from the meeting and complete resolutions
The minutes from the Annual General Meeting will be made available at the Company and on the Company's website, www.mobergpharma.com.
For additional information, please contact:
About this information
The information was submitted for publication at
About
https://news.cision.com/moberg-pharma/r/bulletin-from-moberg-pharma-s-agm-on-may-16-th--2023,c3770684
https://mb.cision.com/Main/1662/3770684/2064705.pdf
(c) 2023 Cision. All rights reserved., source